Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Heart Rhythm Advocates town hall to review key EP policies
Leaders from HRS and Heart Rhythm Advocates will take the stage to explore policy updates, advocacy goals for the future and much more.
To eat or not to eat: Is fasting still necessary before heart procedures?
As one may expect, patient satisfaction was considerably higher for individuals who did not have to fast for a minimum of six hours prior to treatment. There were no other significant differences.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).
Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.

AI-based CAD assessments dramatically improve vascular surgery outcomes

PAD patients evaluated with HeartFlow's noninvasive FFR_CTAnalysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years.

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

Only radiology is associated with more FDA-cleared AI algorithms than cardiology, according to new federal data.

PaceMate names former Philips, BioTelemetry leader its new chief commercial officer

JR Finkelmeier has more than 20 years of experience in the healthcare and medical device industries.

artificial intelligence robot evaluates healthcare data

Medtronic adds new AI models to its insertable cardiac monitors

The new algorithms are automatically applied in the cloud; patients wearing the devices are not required to take any additional steps.

Abbott’s Aveir DR leadless pacemaker, the world’s very first dual-chamber pacing solution of its kind, is associated with a “reliable” performance after six months, according to new data published in Heart Rhythm.[1]

World’s first dual-chamber leadless pacemaker still going strong after 6 months

Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.

Medical device company raises $87M to study new-look scaffolds for BTK PAD

R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO.

HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology

A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston.

Biosense Webster CARTO 3 System Version 8

Biosense Webster updates 3D heart mapping software with advanced AI models

The update includes multiple new algorithms designed to improve efficiency during cardiac ablation procedures.

Cardiac Imaging

Heart Rhythm Advocates town hall to review key EP policies

To eat or not to eat: Is fasting still necessary before heart procedures?

Pulmonary embolism thrombectomy use increases by more than 700%

Private equity-backed Medline files for IPO

Key takeaways for interventional cardiology from TCT 2025